Incitec Pivot (ASX:IPL) announced financial results for the full-year ended 30 September 2022.

Zero Harm: Total Recordable Injury Frequency Rate (TRIFR) of 0.89, stable from 0.87 in the prior corresponding period (pcp), with severity level continuing to decrease.

NPAT ex IMIs: $1,027m, up 186% from $359m on pcp.

Earnings Before Interest and Tax (EBIT) ex IMIs: $1,485m, up 162% from $566m on pcp.

Earnings Per Share ex IMIs of 52.9 cents per share, an increase of 34.4 cents per share on pcp.

Return on invested capital (ROIC) of 13.8%, a significant improvement on pcp of 5.8%.

Strong balance sheet with net debt of $1bn and Net Debt/ EBITDA ratio ex IMIs of 0.5x, down from 1.1x on pcp.

Dyno Nobel Americas (DNA) EBIT of US$533m (US$141m pcp) with continued uptake of premium technology underpinning excellent volume growth in Q&C as well as strong second half manufacturing performance capturing favourable commodity markets.

Dyno Nobel Asia Pacific (DNAP) EBIT of $162m ($140m pcp) reflecting customer growth and solid take up of Dyno?s premium technology solutions.

Fertilisers EBIT increased to $614m ($268m pcp) with Manufacturing more than doubling earnings during the year despite Phosphate Hill undergoing a major turnaround.

Climate Change Strategy: pathway identified to >42% reductions in operational GHG emissions by 2030.

Following the announcement the company?s share price rose 8.556%.